Publication of Final Terms
The following final terms dated 28 November 2014 (the "Final Terms") in respect of the Notes (as defined below) are available for viewing:
GlaxoSmithKline Capital plc issue of:
EUR1,500,000,000 0.625 per cent. Notes due 2019; and
EUR1,000,000,000 1.375 per cent. Notes due 2024,
in each case guaranteed by GlaxoSmithKline plc issued under the £15,000,000,000 Euro Medium Term Note Programme (the "Notes")
Copies of the Final Terms have been submitted to the National Storage Mechanism and will shortly be available for viewing at:
http://www.morningstar.co.uk/uk/NSM.
For further information, please contact:
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Enquiries:
|
UK Media enquiries:
|
David Mawdsley
Sarah Spencer
|
(020) 8047 5502
(020) 8047 5502
|
|
European Analyst/Investor enquiries:
|
Gary Davies
Ziba Shamsi
|
(020) 8047 5503
(020) 8047 5543
|
BASIS ON WHICH YOU MAY ACCESS THE FINAL TERMS AND BASE PROSPECTUS
Please note that the information contained in the Final Terms and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms or the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirements.